181 related articles for article (PubMed ID: 33599424)
1. [Kidney involvement in Waldenström's disease - case report].
Fomasi L; Foini P; Marchi G; Ghiringhelli P; Molteni A; Ungari M; Fisogni S; Malberti F
G Ital Nefrol; 2021 Feb; 38(1):. PubMed ID: 33599424
[TBL] [Abstract][Full Text] [Related]
2. Renal involvement in Waldenström's macroglobulinemia: case report and review of literature.
Salviani C; Guido G; Serriello I; Giannakakis K; Rocca AR
Ren Fail; 2014 Feb; 36(1):114-8. PubMed ID: 24059636
[TBL] [Abstract][Full Text] [Related]
3. Idelalisib in a patient with refractory Waldenström's macroglobulinemia complicated by anuric renal failure: a case report.
D'Aveni-Piney M; Divoux M; Busby-Venner H; Muller M; Broséus J; Feugier P
J Med Case Rep; 2018 Jun; 12(1):164. PubMed ID: 29890999
[TBL] [Abstract][Full Text] [Related]
4. Nephrotic syndrome caused by protein thrombi in glomerulocapillary lumen in Waldenström's macroglobulinaemia.
Harada Y; Ido N; Okada T; Otani M; Shirota T; Nakao T; Hayashi T
Br J Haematol; 2000 Sep; 110(4):880-3. PubMed ID: 11054074
[TBL] [Abstract][Full Text] [Related]
5. Pleural fluid MYD88 L265P mutation supporting diagnosis and decision to treat extramedullary Waldenstrom's macroglobulinemia: a case report.
Barnes M; Sharma P; Kumar V; Kaell A; LiPera W
J Med Case Rep; 2020 Jul; 14(1):98. PubMed ID: 32654665
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin M 'Flare' after rituximab-associated acute tubular necrosis in Waldenström's macroglobulinemia.
Izzedine H; Bourry E; Amrouche L; Brocheriou I; Uzunov M; Capron F; Leblond V; Deray G
Int J Hematol; 2009 Mar; 89(2):218-222. PubMed ID: 19156501
[TBL] [Abstract][Full Text] [Related]
7. Advances in the treatment of Waldenström's macroglobulinemia.
Johnson SA
Expert Rev Anticancer Ther; 2006 Mar; 6(3):329-34. PubMed ID: 16503850
[TBL] [Abstract][Full Text] [Related]
8. Acute renal failure secondary to severe type I cryoglobulinemia following rituximab therapy for Waldenström's macroglobulinemia.
Shaikh A; Habermann TM; Fidler ME; Kumar S; Leung N
Clin Exp Nephrol; 2008 Aug; 12(4):292-295. PubMed ID: 18288560
[TBL] [Abstract][Full Text] [Related]
9. Pentostatin/cyclophosphamide with or without rituximab: an effective regimen for patients with Waldenstrom's macroglobulinemia/lymphoplasmacytic lymphoma.
Hensel M; Villalobos M; Kornacker M; Krasniqi F; Ho AD
Clin Lymphoma Myeloma; 2005 Sep; 6(2):131-5. PubMed ID: 16231851
[TBL] [Abstract][Full Text] [Related]
10. Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's Macroglobulinemia.
Buske C; Dimopoulos MA; Grunenberg A; Kastritis E; Tomowiak C; Mahé B; Troussard X; Hajek R; Viardot A; Tournilhac O; Aurran T; Lepretre S; Zerazhi H; Hivert B; Leblond V; de Guibert S; Brandefors L; Garcia-Sanz R; Gomes da Silva M; Kimby E; Schmelzle B; Kaszynski D; Dreyhaupt J; Muche R; Morel P
J Clin Oncol; 2023 May; 41(14):2607-2616. PubMed ID: 36763945
[TBL] [Abstract][Full Text] [Related]
11. Recovery of kidney function by rituximab-based therapy in a patient with Waldenström's macroglobulinemia-related nephropathy presenting cast nephropathy and interstitial lymphocytic infiltration.
Miwa M; Sakao Y; Ishigaki S; Ono M; Fujikura T; Yasuda H; Suzuki H; Kato A; Nagata Y; Shigeno K; Nakamura S; Ohnishi K; Fujigaki Y
Intern Med; 2012; 51(13):1725-30. PubMed ID: 22790134
[TBL] [Abstract][Full Text] [Related]
12. Novel agents in the treatment of Waldenström's macroglobulinemia.
Treon SP; Hatjiharissi E; Leleu X; Moreau AS; Roccaro A; Hunter ZR; Soumerai JD; Ciccarelli B; Xu L; Sacco A; Ngo HT; Jia X; Yang C; Adamia S; Branagan AR; Ho AW; Santos DD; Tournilhac O; Manning RJ; Leduc R; O'Connor K; Nelson M; Patterson CJ; Ghobrial I
Clin Lymphoma Myeloma; 2007 Aug; 7 Suppl 5():S199-206. PubMed ID: 17877845
[TBL] [Abstract][Full Text] [Related]
13. Waldenstrom Macroglobulinemia/Lymphoplasmacytic Lymphoma Associated with Nephrotic Syndrome during Hemodialysis, Treated Successfully with Tirabrutinib.
Sekiguchi Y; Nishimura Y; Kanda H; Kawamura M; Kobayashi K; Kobayashi H
Intern Med; 2022 Aug; 61(16):2503-2508. PubMed ID: 35110483
[TBL] [Abstract][Full Text] [Related]
14. Bilateral, persistent serous macular detachments with Waldenström's macroglobulinemia.
Pilon AF; Rhee PS; Messner LV
Optom Vis Sci; 2005 Jul; 82(7):573-8. PubMed ID: 16044069
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report.
Hasegawa K; Kubota K; Hirai H; Imai Y; Midorikawa Y; Makuuchi M
Hepatogastroenterology; 2000; 47(33):842-5. PubMed ID: 10919044
[TBL] [Abstract][Full Text] [Related]
16. Lymphoplasmacytic lymphoma with IgA paraproteinemia mimicking Waldenstrom's Macroglobulinemia.
Basu D; Pathak D; Shyambabu C; Koner BC; Swaminathan RP
Indian J Pathol Microbiol; 2004 Oct; 47(4):515-7. PubMed ID: 16295380
[TBL] [Abstract][Full Text] [Related]
17. Rituximab, Cyclophosphamide, Dexamethasone (RCD) regimen induces cure in WSU-WM xenograft model and a partial remission in previously treated Waldenstrom's macroglobulinemia patient.
Mohammad RM; Aboukameel A; Nabha S; Ibrahim D; Al-Katib A
J Drug Target; 2002 Aug; 10(5):405-10. PubMed ID: 12442811
[TBL] [Abstract][Full Text] [Related]
18. Waldenström's macroglobulinemia as a diagnostic challenge: case report.
Budimir I; Nikolić M; Pusić MS; Hrabar D; Ljubicić N; Duvnjak M; Supanc V; Nikolac I; Babić N; Sokcević M
Acta Clin Croat; 2014 Mar; 53(1):94-7. PubMed ID: 24974671
[TBL] [Abstract][Full Text] [Related]
19. Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial.
Dimopoulos MA; Trotman J; Tedeschi A; Matous JV; Macdonald D; Tam C; Tournilhac O; Ma S; Oriol A; Heffner LT; Shustik C; García-Sanz R; Cornell RF; de Larrea CF; Castillo JJ; Granell M; Kyrtsonis MC; Leblond V; Symeonidis A; Kastritis E; Singh P; Li J; Graef T; Bilotti E; Treon S; Buske C;
Lancet Oncol; 2017 Feb; 18(2):241-250. PubMed ID: 27956157
[TBL] [Abstract][Full Text] [Related]
20. [A rare cause of pulmonary opacities: Lung localization of Waldenström's macroglobulinemia].
Monnet CM; Favrolt N; Bastie JN; Chrétien ML; Benoit F; Rossi C; Camus P; Bonniaud P
Rev Mal Respir; 2014 Sep; 31(7):632-5. PubMed ID: 25239587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
